Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 7;16(9):1110-4.
doi: 10.3748/wjg.v16.i9.1110.

Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test

Affiliations

Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test

Motoaki Kuriyama et al. World J Gastroenterol. .

Abstract

Aim: To examine the feasibility of predicting the flare-up of ulcerative colitis (UC) before symptoms emerge using the immunochemical fecal occult blood test (I-FOBT).

Methods: We prospectively measured fecal hemoglobin concentrations in 78 UC patients using the I-FOBT every 1 or 2 mo.

Results: During a 20 mo-period, 823 fecal samples from 78 patients were submitted. The median concentration of fecal hemoglobin was 41 ng/mL (range: 0-392 500 ng/mL). There were three types of patients with regard to the correlation between I-FOBT and patient symptoms; the synchronous transition type with symptoms (44 patients), the unrelated type with symptoms (19 patients), and the flare-up predictive type (15 patients). In patients with the flare-up predictive type, the values of I-FOBT were generally low during the study period with stable symptoms. Two to four weeks before the flare-up of symptoms, the I-FOBT values were high. Thus, in these patients, I-FOBT could predict the flare-up before symptoms emerged.

Conclusion: Flare-up could be predicted by I-FOBT in approximately 20% of UC patients. These results warrant periodical I-FOBT in UC patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A histogram of hemoglobin concentrations in 823 fecal samples. The distribution of hemoglobin concentration in 823 fecal samples from 78 UC patients is shown. The median concentration was 41 ng/mL (0-392 500 ng/mL). More than 50% of fecal samples exhibited values between 0 and 100 ng/mL. Approximately 20% were between 100-1000 ng/mL, 15% were between 1000-10 000 ng/mL, and the remaining 7% of samples exhibited values more than 10 000 ng/mL. In general, stools with a hemoglobin concentration more than 1000-10 000 ng/mL were recognized as bloody stools.

Similar articles

Cited by

References

    1. Allison JE. Review article: faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther. 1998;12:1–10. - PubMed
    1. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol. 2005;100:1393–1403. - PubMed
    1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–1371. - PubMed
    1. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477. - PubMed
    1. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471. - PubMed